Cravatt Benjamin
SEC CIK 1819573 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KYNB | KYNTRA BIO, INC. | Dir | 28.7K | — | $67.7K | 3 | 2022-06-16 | 2023-06-09 |
Most active insiders at KYNB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wettig Thane | CEO, Dir | $33.8K | — |
| 2 | DeLucia David | CFO | — | — |
Cravatt Benjamin made no open-market trades at KYNB in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-09 | 2023-06-07 | KYNB | KYNTRA BIO, INC. | Cravatt Benjamin | Dir | A - Grant | $0.00 | +8,289 | 32.7K | +34% | $0 |
| DM | 2023-06-09 | 2023-06-09 | KYNB | KYNTRA BIO, INC. | Cravatt Benjamin | Dir | S - Sale | $17.17 | -3,944 | 28.7K | -12% | -$67.7K |
| D | 2022-06-21 | 2022-06-16 | KYNB | KYNTRA BIO, INC. | Cravatt Benjamin | Dir | A - Grant | $0.00 | +15.8K | 24.4K | +183% | $0 |
Purchase Sale Sale after option exercise All abbreviations